换一批摘要篇首： Visceral leishmaniasis (VL), also known as kala-azar, is a vector-borne disease caused by protozoa of the Leishmania donovani complex. It is usually fatal if untreated. Pentavalent antimonials have been the mainstay of treatment for more than 60 years, but these drugs have serious side effects and progressive antimonial resistance.1 Other proven therapeutics such as amphotericin B, pentamidine, and paromomycin are costly without oral formulation and unpleasant side effects.2 Thus, new chemotherapeutic drugs are required to supplement or replace currently available drugs.
更多相关知识
栏目名称
发布时间
2004-10-09（万方平台首次上网日期，不代表论文的发表时间）
- 浏览95
- 被引8
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
